Skip to main content

454 Life Sciences to Offer GenomeQuest Informatics with GS FLX System

NEW YORK (GenomeWeb News) – Roche’s 454 Life Sciences has inked a co-marketing deal with GenomeQuest, whereby GenomeQuest will offer its On-Demand Informatics Service to users of 454’s Genome Sequencer FLX.
According to a statement from 454, GenomeQuest’s high-throughput annotation and data-management tools enable rapid characterization of sequences generated by the GS FLX system. The co-marketing pact was signed following a pilot study to evaluate the scientific accuracy and scalability of GenomeQuest’s algorithms and informatics platform, said 454.
“When GenomeQuest first proposed to us the ability to computationally screen all of the sequences of an instrument run in one pass to provide annotated reads to our customers, we were hopeful, but cautious,” Edward Szekeres, manager of production informatics for 454, said in a statement. “Ultimately, they exceeded our expectations for each test case.”

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.